MD Anderson Cancer Center and MD Anderson Physicians Network Symposium-

Page 1

MD Anderson Cancer Center and MD Anderson Physicians Network Symposium

Changing Paradigms in Cancer Treatment and Patient Management

July 30–August 2, 2011 Nursing Excellence:

Caring for the Whole Patient

July 30–31, 2011

JW Marriott 500 Post Street San Francisco, California


MD Anderson Cancer Center and MD Anderson Physicians Network Symposium

Changing Paradigms in Cancer Treatment and Patient Management July 30–August 2, 2011 Nursing Excellence: Caring for the Whole Patient July 30–31, 2011 JW Marriott 500 Post Street San Francisco, California

Goal

This symposium will consist of four days focused on providing information on the changing paradigms in diagnostic and therapeutic interventions as they pertain to cancer treatment and management of selected tumor types. Many of the didactic presentations and interactive case presentations with the audience are designed to highlight new information and answer controversial oncologic questions. The practitioner attending the symposium will receive the updated information from MD Anderson Cancer Center faculty and national clinical leaders. This program is intended to improve practitioner knowledge and performance, patient management and outcomes.

Target Audience

The information provided during this symposium will be beneficial to medical oncologists, hematologists, radiation oncologists, surgical oncologists, general surgeons, thoracic surgeons, internists, physician assistants, advanced practice nurses and oncology nurses involved in the care of patients with breast, colorectal, esophageal, head and neck, hematologic, non-small cell lung, pancreatic and prostate cancers.

ORGANIZING COMMITTEE Richard J. Babaian, MD Miloslav Beran, MD, PhD Helmuth Goepfert, MD Kelly K. Hunt, MD, Co-Chair Merrill S. Kies, MD, Co-Chair

Deborah A. Kuban, MD, Co-Chair Peter W. McLaughlin, MD William J. Simeone, Jr., MHA Camerone A. Spoons, MBA Constance C. Tierney, CMP

Educational Objectives After attending the symposium, participants should be able to • Identify and apply the changing paradigms in cancer treatment that pertain to patients with breast, colorectal, esophageal, head and neck, NSCLC, hematologic, pancreatic and prostate cancers (Knowledge, Competence, Performance); • Describe and apply novel diagnostic and cancer therapeutic approaches now being used and accepted that impact patient management and outcomes (Knowledge, Competence, Performance, Patient Outcomes); • Adopt the role and timing of each discipline (medical, radiation, and surgery) in patient management (Knowledge, Competence, Performance); • Implement new knowledge in patient management for better outcomes (Knowledge, Competence, Performance, Patient Outcomes).

Educational Method

Lectures – Case Presentation Including Interactive Audience Participation – Questions and Answers

Evaluation

A course evaluation form will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.

Accreditation/Credit Designation

The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 25.25 live AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

CME Certificates and Attendance Verification Certificates

Certificates awarding AMA PRA Category 1 CreditTM or certificates documenting attendance will be distributed to participants when an individual departs the conference. To obtain a CME certificate, physicians must submit a completed evaluation questionnaire and a CME Verification Form. Upon request, a record of attendance (certificate) will be provided on-site to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.


10:50

Program

Saturday, July 30, 2011

6:30 a.m.

Continental Breakfast/Registration

7:00

Introduction and Welcome William A. Murphy, Jr., MD

12:50

7:10

Keynote Speaker Cancer Care Delivery in a Time of Healthcare Reform Thomas W. Feeley, MD

THORACIC/ESOPHAGEAL/HEAD & NECK CANCERS

8:00 8:20

11:20

Current Approaches in the Management of Squamous Cell and Adenocarcinoma of the Esophagus Stephen G. Swisher, MD Combined Modality Management for Head and Neck Cancer Patients with HPV-Positive Disease: Strategies to Maintain Efficacy and Reduce Long Term Toxicity Merrill S. Kies, MD

New Evidence for IMRT and Proton Therapy and the Emerging Role for Both in the Management of Head and Neck Cancers Steven J. Frank, MD

12:10 p.m.

Break

12:25

Appropriate Imaging for Diagnostic and Follow-Up of Head and Neck Cancer Lawrence E. Ginsberg, MD

11:45

Challenging Thoracic, Esophagus, and Head and Neck Case Presentations and Interactive Audience Participation Moderator: Merrill S. Kies, MD Thoracic, Esophagus, and Head and Neck Speakers

2:00

Adjourn

6:30–8:30 p.m.

Welcome Reception

Lung Cancer Screening Works! Now What? Reginald F. Munden, MD

Sunday, July 31, 2011

What is the Surgeon’s Participation in Contemporary Management of Lung Cancer? Stephen G. Swisher, MD

6:45 a.m.

Continental Breakfast/Registration

BREAST CANCER

7:00

Introduction Kelly K. Hunt, MD

7:05

Breast Cancer Screening and the Impact of Breast Density Wei Yang, MD

7:25

Genetic Testing and the Impact on Decision Making Banu K. Arun, MD

8:45 Break 8:55

Small Cell Lung Cancer: Current Strategies and New Directions Bonnie S. Glisson, MD

9:20

Non-Small Cell Lung Cancer: Combined Modality Therapy for Patients with Stage II/III Disease Scott M. Lippman, MD

9:45

7:45

Stereotactic and Proton Radiation for Non-Small Cell Lung Cancer Melenda Jeter, MD, MPH

Processing of Sentinel Nodes and the Significance of Micrometastases Aysegul A. Sahin, MD

10:10

Advances in Novel Therapeutics for Lung Cancer Edward S. Kim, MD

8:05

Excisional Biopsy for Breast Cancer Diagnosis is Not Justified Anthony Lucci, MD

10:40 Break

8:25 Break


Should We Still Be Performing Axillary Lymph Node Dissection In Breast Cancer? Kelly K. Hunt, MD

9:00

Partial Breast Irradiation Elizabeth S. Bloom, MD

9:20

What is the Appropriate Margin in Breast Conserving Surgery? Karen Hoffman, MD

9:40

HER-2 Testing in Breast Cancer: What Are the Issues? Aysegul A. Sahin, MD

8:40

10:00 Break 10:15

Making Sense of Multigene Assays in Practice Ana M. Gonzalez-Angulo, MD

10:35

When Should We Use MRI in Breast Cancer Follow-Up? Wei Yang, MD

10:55

HER-2 Directed Therapies: Adjuvant or Neoadjuvant? Ana M. Gonzalez-Angulo, MD

11:15

What is the Role for Surgical Resection in Patients with Stage IV Disease? Kelly K. Hunt, MD

11:35 Break 11:50 The Case for Postmastectomy Radiation Therapy Karen Hoffman, MD 12:10 p.m.

Do Circulating Tumor Cells and Disseminated Tumor Cells Add Value in Prognosis and Treatment? Anthony Lucci, MD

12:30

Challenging Breast Cancer Case Presentations and Interactive Audience Participation Moderator: Kelly K. Hunt, MD Breast Cancer Speakers

HEMATOLOGIC CANCERS

7:45

Lymphoma and Myeloma Introduction Peter W. McLaughlin, MD

7:50

PET Scan in Lymphoma: Which Histologies? When? Can it Guide Treatment? Fredrick B. Hagemeister, MD

8:15

Therapy Selection in DLBCL Based on Molecular Subtype Sven de Vos, MD, PhD

8:40

Break

8:50

New Therapeutic Targets in Lymphoma: The B-cell Receptor, CD-30 Fredrick B. Hagemeister, MD

9:15

Front Line Combination and Maintenance Strategies In Myeloma Sheeba K. Thomas, MD

9:40

Leukemia Introduction Miloslav Beran, MD, PhD

9:45

Emerging Paradigms in the Management of Myeloproliferative Disorders Stefan H. Faderl, MD

10:10

Molecular Markers Guiding Diagnosis and Optimizing Management of Leukemias Stefan H. Faderl, MD

10:35 Break 10:45

Challenging Lymphoma, Myeloma, and Leukemia Case Presentations and Interactive Audience Participation Moderators: Miloslav Beran, MD, PhD; Peter W. McLaughlin, MD Lymphoma, Myeloma and Leukemia Speakers

11:45 Break

MISCELLANEOUS

2:00 Adjourn

Noon

Active Surveillance vs. Treatment in the Management of Prostate Cancer Deborah A. Kuban, MD

Monday, August 1, 2011

12:25 p.m.

New Options for Therapy in Localized Pancreatic Cancer Jason B. Fleming, MD

12:50

Dose Escalation and Stereotactic Therapy in the Management of Pancreatic Cancer Sunil Krishnan, MD

1:15

Challenging Case Presentations and Interactive Audience Participation Moderators: Jason B. Fleming MD, and Deborah A. Kuban, MD Session Speakers

2:00

Adjourn

6:45 a.m.

Continental Breakfast/Registration

7:00

Introduction Merrill S. Kies, MD

7:05 Keynote Lecture ASCO Highlights 2011: Practice Changing Research Everett E. Vokes, MD


Tuesday, August 2, 2011

6:45 a.m.

Continental Breakfast/Registration

12:10 p.m.

Break

12:25

Challenging Colorectal Cancer Case Presentations and Interactive Audience Participation Moderator: George J. Chang, MD Colorectal Speakers Adjourn

COLORECTAL CANCERS

7:00

Introduction George J. Chang, MD

2:00

7:05

Image Enhanced Endoscopic Detection and Advanced Endoscopic Intervention of Colorectal Neoplasia Roy Soetikno, MD

MD ANDERSON FACULTY

7:30

Imaging Evaluation of Colorectal Cancer: X-rays, Magnets or Metabolic Agents? Harmeet Kaur, MD

7:55

Adjuvant Chemotherapy for Colorectal Cancer: Where To Now? Cathy Eng, MD

8:20

Immunohistochemistry, PCR, and Genomics for Colorectal Pathology: When, Why, and For Whom? Melissa Taggart, MD

8:45 Break 9:00

Diffusion Weighted MRI in Staging and Response Monitoring for Rectal Cancer Harmeet Kaur, MD

9:25

Advances in RT: IMRT, Short Course and Selective Omission of RT Sunil Krishnan, MD

9:50

Advances in Minimally Invasive Surgery for Rectal Cancer: Local Excision or Robotics? George J. Chang, MD

10:15

Making Sense of the Alphabet Soup in Advanced Colorectal Cancer: Novel Agents in Preclinical Development Cathy Eng, MD

10:40 Break 10:55

Surgical Therapy for Metastatic Colorectal Cancer: When to Refer and To Whom? Thomas A. Aloia, MD

11:20

Quality Assurance and Recurrence Risk Reduction in the Surgical Treatment of Colorectal Cancer George J. Chang, MD

11:45

What the Blood Compartment Can Teach Us About Colorectal Cancer: Circulating Tumor Cells and DNA Melissa Taggart, MD

Thomas A. Aloia, MD Assistant Professor Surgical Oncology Banu K. Arun, MD Professor Breast Medical Oncology Miloslav Beran, MD, PhD Adjunct Professor, Leukemia Medical Director MD Anderson Physicians Network Elizabeth S. Bloom, MD Associate Professor Radiation Oncology George J. Chang, MD Associate Professor Surgical Oncology Cathy Eng, MD Associate Professor Gastrointestinal Medical Oncology Stefan H. Faderl, MD Associate Professor Leukemia Thomas W. Feeley, MD Division Head and Professor Anesthesiology and Critical Care Vice President for Medical Operations Jason B. Fleming, MD Associate Professor Surgical Oncology Steven J. Frank, MD Assistant Professor Radiation Oncology Bonnie S. Glisson, MD Professor Thoracic/Head and Neck Medical Oncology Lawrence E. Ginsberg, MD Professor Diagnostic Imaging Ana M. Gonzalez-Angulo, MD Associate Professor Breast Medical Oncology Fredrick B. Hagemeister, MD Professor Lymphoma/Myeloma Karen Hoffman, MD Assistant Professor Radiation Oncology

Kelly K. Hunt, MD Professor and Chief Surgical Breast Section Surgical Oncology

Stephen G. Swisher, MD Professor and Chair Thoracic and Cardiovascular Surgery

Melinda Jeter, MD, MPH Associate Professor Radiation Oncology

Melissa Taggart, MD Assistant Professor Pathology and Laboratory Medicine

Harmeet Kaur, MD Associate Professor Diagnostic Imaging Merrill S. Kies, MD Professor Thoracic/Head and Neck Medical Oncology Edward S. Kim, MD Associate Professor Thoracic/Head and Neck Medical Oncology Sunil Krishnan, MD Associate Professor Radiation Oncology Deborah A. Kuban, MD Professor and Chief Genitourinary Section Radiation Oncology Scott M. Lippman, MD Chair and Professor Thoracic/Head and Neck Medical Oncology Anthony Lucci, MD Professor Surgical Oncology Peter W. McLaughlin, MD Professor Emeritus Lymphoma/Myeloma Medical Director MD Anderson Physicians Network Reginald F. Munden, MD Professor Diagnostic Imaging William A. Murphy, Jr., MD Professor, Diagnostic Imaging Board Chairman MD Anderson Physicians Network Aysegul A. Sahin, MD Professor and Chief Breast Section Pathology and Laboratory Medicine

Sheeba K. Thomas Assistant Professor Lymphoma/Myeloma Wei Yang, MD Professor Diagnostic Imaging

GUEST SPEAKERS Sven de Vos, MD, PhD Professor Department of Hematology UCLA Medical Center Los Angeles, California Roy Soetikno, MD Gastroenterologist Palo Alto Veteran’s Hospital Palo Alto, California Everett E. Vokes, MD Professor and Chair Department of Medicine University of Chicago Medical Center Chicago, Illinois


Saturday, July 30, 2011

6:15 a.m.

Registration/Continental Breakfast

6:45

Introduction and Welcome Laurie Sturdevant, BA, RN, OCN

7:00

Keynote Speaker: Leading Change and Advancing Health: Nurses Transforming Quality and Safety in Care Paula Rieger, RN, MSN, CAE, FAAN

Caring for the Whole Patient

8:00

Survivorship: Living Beyond Cancer Fran Zandstra, BSN, MBA, RN, OCN

(See registration form for separate registration and fee. For those wishing to attend the Monday and Tuesday of the symposium, the cost will be $75 additional.)

9:15

A Patient’s Perspective on Surviving Cancer Bettina Wade

10:15

Cognition and Cancer, and Cancer Treatment Jennie Rexer, PhD, BS

July 30–31, 2011

Nursing Excellence:

GOAL

A separate two-day conference is designed to reinforce nursing care standards identifying not only the physical needs of oncology patients, but emphasizing the treatment and care of the whole patient to include emotional, psycho-social, and supportive concerns.

Nursing Program

9:00 Break

11:15 Break 12:15 p.m.

Radiation Therapy and Long-Term/Late Effects Impacting Survivors Phyllis Evetts, RN, MSN, CNS, ANP-BC, OCN

After attending the conference, participants should be able to - Provide a patient’s perspective on surviving cancer; - Showcase certain cancer treatments and their effects on the whole patient; - Provide the latest in tools available for assessing the entire patient; - Discuss feasible options for addressing the needs of the whole cancer patient; - Discuss options for incorporating care interventions into participants’ practice.

1:30

Caring for Patients Receiving Radiation and Chemotherapy for Head and Neck Cancers Ginny Bowman, MSN, AOCNS, CNS, CORLN, OCN, RN

2:45

Adjourn

NURSING CREDITS

Nursing Continuing Education Contact Hours will be awarded.

The University of Texas MD Anderson Cancer Center is an approved provider of continuing nursing education by the Texas Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

6:15 a.m.

Sunday, July 31, 2011

Registration/Continental Breakfast

6:45

Introduction and Welcome Janice L. Kitchens, BSN, RN, OCN

7:00

Patient Adherence With Oral Agents for Chronic Myelogenous Leukemia (CML) Patricia Ault, MS, ACNP, ANP, CNS, FNP, NP, RN

8:15

Meeting the Psycho-Social Needs of Cancer Patients Kathleen Rickman, MS, DRPH, CARN, CNS, LCDC, RN

9:30

Break

EDUCATIONAL OBJECTIVES

ORGANIZING COMMITTEE Lisa G. Green, MSN, RN, AOCN Program Manager, NPDE MD Anderson Houston, Texas Janice L. Kitchens, BSN, RN, OCN, Co-Chair Manager, Healthcare Services MD Anderson Physicians Network Houston, Texas Vicki May, CRNP, AOCNP Nurse Practitioner DCH Cancer Center Tuscaloosa, Alabama

Gayle Marble, BSN, RN, OCN Oncology Educator Banner Good Samaritan Medical Center Phoenix, Arizona Laurie Sturdevant, BA, RN, OCN, Co-Chair Manager, Quality Improvement MD Anderson Physicians Network Houston, Texas Carme Tripp, BN, MHA, OCN Director, Oncology Nursing Southcoast Centers for Cancer Care New Bedford, Massachusetts

2:30 Evaluation


9:45

Cancer Rehabilitation: An Overview Janet S. Scheetz PT, CLT-LANA; Lauro A. Munoz, MS, OTR Chocolate? Wine? Cancer Fighting Facts for the Survivor Sally Scroggs, MS, LD, RD

11:00 12:15 p.m. Break 1:00 Patient Navigation: A New Wave of Improving Patient Care Susan Stary, BSN, OCN, RN 2:00 Evaluation 2:15 Adjourn

Nursing Program

Registration Information

On-site registration for the MD Anderson Cancer Center and MD Anderson Physicians Network Symposium opens at 6:30 a.m. on Saturday, July 30, 2011. The opening session of the symposium will begin at 7:00 a.m. on Saturday, July 30, 2011, and the symposium will adjourn on Tuesday, August 2, 2011. On-site registration for Nursing Excellence: Caring for the Whole Patient opens at 6:15 a.m. on Saturday, July 30, 2011. The opening session of the conference will begin at 6:45 a.m., and the conference will adjourn on Sunday, July 31, 2011. Advance registration is encouraged as space and materials are limited. Please see registration form for applicable fees. The deadline for advance registration is July 8, 2011. There are three ways to register: • Mail to: CME/Conference Management – Unit 1381, The University of Texas MD Anderson Cancer Center, P.O. Box 301439, Houston, TX 77230-1439 • Fax to: 713-794-1724 • On-line at www.mdanderson.org/conferences We accept the following forms of payment: • Check (payable through U.S. banks only) • Money Order • Credit Cards (MasterCard, VISA, and American Express) • Cash (on-site registration only) A receipt and confirmation letter will be sent to you within ten working days of receipt of your fee.

MD ANDERSON FACULTY Patricia Ault, MS, ACNP, ANP, CNS, FNP, NP, RN Coordinator, Clinical Studies Symptom Research

Janet S. Scheetz, PT, CLT-LANA Outpatient Physical Therapy Supervisor Rehabilitation Services

Ginny Bowman, MSN, AOCNS, CNS, CORLN, OCN, RN Advanced Practice Nurse Nursing

Sally Scroggs, MS, LD, RD Manager, Health Education Cancer Prevention Center

Phyllis Evetts, RN, MSN,CNS, ANP-BC, OCN Advanced Practice Nurse Bay Area Regional Care Center

Susan Stary, BSN, OCN, RN Quality Management Analyst Physicians Network

Lauro A. Munoz, MS, OTR Occupational Therapy Supervisor Rehabilitation Services

Fran Zandstra, BSN, MBA, RN, OCN Director, Cancer Survivorship Program VP Medical Affairs

Jennie Rexer, PhD, BS Assistant Professor Neuro-Oncology Kathleen Rickman, MS, DRPH, CARN, CNS, LCDC, RN Advanced Practice Nurse Psychiatry

GUEST FACULTY Paula Rieger, RN, MSN, CAE, FAAN Chief Executive Officer Oncology Nursing Society Pittsburgh, Pennsylvania

Bettina Wade Cancer Survivor

The full conference registration fee includes the tuition, abstract CD, continental breakfasts, breaks, and welcome reception.

Refund/Cancellation Policy: The registration fee, minus a $50 administrative handling fee, is refundable if a written request is received on or before July 8, 2011. No refunds will be granted after that date. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. Although no refunds will be granted after July 8, 2011, you may transfer your registration to a colleague. The Department of CME/Conference Management reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary. Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form. In case of activity cancellation, liability of the Department of CME/Conference Management is limited to the registration fee. CME/Conference Management will refund the full registration fee. The Department of CME/Conference Management reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. For additional information, contact CME/Conference Management at 713-792-2223 or toll free at 866-849-5866.


IDT Approver Name (First/Last) please print

IDT Approver E-mail

1 $75 additional to attend Symposium August 1–2

Nursing Excellence: Caring for the Whole Patient - July 30–31, 2011 1 Postmarked before 7/8/11........................$325.00 1 Postmarked after 7/8/11...........................$350.00 MD Anderson Employee ID No. (REQUIRED) Authorized Signature REQUIRED for credit card or IDT

Expiration Date

Fellows, Physician Assistants, Nurses, Residents 1 Postmarked before 7/8/11........................$350.00 1 Postmarked after 7/8/11...........................$375.00 Credit Card Number or MD Anderson Interdepartmental Transfer (IDT) No.

oAmerican Express

Credit Card Holder Billing Address & ZIP Code

oMasterCard oVISA Charge the following:

Credit Card Holder Name (First/Last)

MD Anderson Alumni/Physicians Network 1 Postmarked before 7/8/11........................$450.00 1 Postmarked after 7/8/11...........................$500.00

Emergency Contact E-mail Address

City

Phone (with area code)

Symposium, July 30–August 2, 2011 Physicians (MDs, PhDs, DOs) 1 Postmarked before 7/8/11........................$550.00 1 Postmarked after 7/8/11...........................$600.00

REGISTRATION FEES

State/Foreign Country/Zip or Mail Code

Specialty

Highest Degree

Cell Phone (with area code) Fax (with area code)

Please let us know what specific topics, issues or questions you wish to see addressed or emphasized in this activity. Fax or e-mail CME/Conference Management. All responses will be forwarded to the Program Chairs for consideration.

Daytime Phone (with area code)

Photographing, audio taping and videotaping are prohibited.

Street

Agendas are subject to change because we are always striving to improve the quality of your educational experience. MD Anderson may substitute faculty with comparable expertise on rare occasions necessitated by illness, schedule conflicts, and so forth.

Institution

The University of Texas MD Anderson Cancer Center has implemented a process whereby everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest that could potentially affect the information presented. MD Anderson also requires that all faculty disclose any unlabeled use or investigational use (not yet approved for any purpose) of pharmaceutical and medical device products. Specific disclosure will be made to the participants prior to the educational activity.

Department (include box no.)

The hotel is approximately 14 miles from San Francisco International Airport and 20 miles from the Oakland Airport. Taxis are available at the approximate price of $40 one way from SFO and $60 one way from OAK. Super Shuttle is also available. Please call 415-558-8500 or book on line at www.supershuttle.com.

SYMPOSIUM REGISTRATION - 0528

Ground Transportation

MI

MD Anderson has a program with Continental Airlines for discounted air travel. For discounts, call your travel professional or Continental’s MeetingWorks toll free at 800-468-7022. Outside of the United States, please call your local Continental Airlines Reservation Office. Mention Z Code: ZJMD and Agreement Code: 325945.

First

Air Travel

Last Name

• A block of rooms has been reserved for symposium attendees at the JW Marriott San Francisco Union Square, 500 Post Street, San Francisco California. • Early hotel reservation is suggested. • The hotel phone number is 415-771-8600. • When you make reservations be sure to mention The University of Texas MD Anderson Cancer Center and the MD Anderson Physicians Network Symposium to be assured of receiving the special meeting rate of $199.00 single or double occupancy. Please add 15.76% California state and local taxes. • The deadline to receive the special rate is July 8, 2011, unless the room block has already been filled.

THIS IS NOT A SELF-MAILER-Address to:

Accommodations

The University of Texas MD Anderson Cancer Center and MD Anderson Physicians Network Symposium Department of CME/Conference Management – Unit 1381 The University of Texas MD Anderson Cancer Center PO Box 301439, Houston, TX 77230-1439 or fax to 713-794-1724 Make check or money order payable to: The University of Texas MD Anderson Cancer Center

Contact the Department of CME/Conference Management at 713-792-2223 or toll free at 866-849-5866 if you have any special dietary or ADA accommodation needs.

MD Anderson Cancer Center and MD Anderson Physicians Network Symposium Changing Paradigms in Cancer Treatment and Patient Management – July 30–August 2, 2011 Nursing Excellence: Caring for the Whole Patient – July 30–31, 2011

Special Assistance


Department of CME/Conference Management - Unit 1381 The University of Texas MD Anderson Cancer Center # 176700/30070528 PO Box 301439 Houston, TX 77230-1439

Non-Profit Org. U.S. Postage PAID Houston, TX Permit No. 7052


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.